Peregrine Pharmaceuticals (PPHM) Soars: Stock Adds 14.5% in Session

Zacks

Peregrine Pharmaceuticals, Inc. (PPHM) was a big mover last session, as the company saw its shares rise over 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up nearly 24% in the past one-month time frame.

The company has seen a mixed track record. There has been one upward revision and one downward revision over the past 30 days, while the Zacks Consensus Estimate has not been in a trend either. Yesterday’s price jump is encouraging though, so make sure to keep a close watch on this firm in the near future.
 
Peregrine Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

However, better-ranked stocks in the biomedicine/gene medical industry include Aastrom Biosciences, Inc. (ASTM), Gentium S.p.A (GENT) and Heska Corp. (HSKA). All these carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



PEREGRINE PHARMACEUTICALS INC (PPHM): Free Stock Analysis Report

AASTROM BIOSCIENCES INC (ASTM): Free Stock Analysis Report

GENTIUM SPA GENTIUM SPA ADS ADSS (GENT): Free Stock Analysis Report

HESKA CORP (HSKA): Free Stock Analysis Report


Zacks Investment Research

Rates

View Comments (0)